SclerodermaSalfordManchester

Scleroderma research at the University of Manchester & Salford Royal Hospital.
For nailfold capillaroscopy research from our group, check out @McrNCM

[World Scleroderma Foundation @Worldsclerofnd]

🎙️ LIVE at #WSC2026
World Scleroderma Congress Highlights Podcast Chaired by Blaz Burja Speakers: Prof. Vanessa Smith & Dr. Michael Hughes
What are the key take-home messages from this year’s congress?What will change practice tomorrow?
Listen now: https://t.co/YyJFo66GP2

[SclerodermaSalfordManchester @SclerodermaM]

Celebrating International Womens Day 2026 at the Systemic Sclerosis World Congress in Athens! #InternationalWomensDay

[SclerodermaSalfordManchester @SclerodermaM]

The team arrives at the venue!

[SclerodermaSalfordManchester @SclerodermaM]

An early start for the team! On our way to Athens for the 9th Systemic Sclerosis World Congress

[SclerodermaSalfordManchester @SclerodermaM]

Do you suffer with bowel accidents & scleroderma? Tell us how living with bowel accidents affects you & what support you received, to help future research! Complete the survey: https://t.co/erjSsQ0kNq

@NCAresearchNHS @WeAreSRUK @alessia_alunno @delgaldoFrances @Worldsclerofnd

[SclerodermaSalfordManchester @SclerodermaM]

🚨Patients with Systemic Sclerosis ('Scleroderma') survey alert🚨
Complete our anonymous questionnaire on faecal incontinence symptoms to influence the future of research here! https://t.co/erjSsQ0kNq

@Worldsclerofnd @WeAreSRUK @delgaldoFrances @NCAresearchNHS @alessia_alunno

[Cristiana Sieiro Santos @cristianasieiro]

📢 Participate in the @Worldsclerofnd Very Early Diagnosis of Systemic Sclerosis (VEDOSS) Survey!
Your insights will:
✔️ Identify key challenges
✔️ Highlight unmet needs
✔️ Shape future education & research

🔗 https://t.co/gkNsTZ3Pos

[Scarlett Prentice @scarlettrosep97]

So exciting all my fundraising merchandise has arrived, for my first London Marathon 💚 🇬🇧 for @WeAreSRUK Time to make a difference💙 #scleroderma #raynauds donate below or share if you can 🙏🏻 💪🏻 https://t.co/nm6jJRnTcu

[SclerodermaSalfordManchester @SclerodermaM]

Excellent work from our group with help from colleagues in Leeds and Santiago, Chile

[NCA Research NHS @NCAresearchNHS]

Latest from our experts @ncalliance_nhs @sclerodermaM
Thermographic abnormalities associate with electrocardiogram/echocardiographic changes and mortality in systemic sclerosis, suggesting a way forward in detecting cardiac involvement in Ssc https://t.co/BuGNUPJcLl

[SclerodermaSalfordManchester @SclerodermaM]

🚨Patients with systemic sclerosis survey alert 🚨
Questionnaire on ORAL HEALTH 👄 needs of people with systemic sclerosis (on behalf of the SCTC Orofacial in SSc Working Group)

https://t.co/DRzE0uuPT7

@WeAreSRUK @Worldsclerofnd @EUSTAR_org @delgaldoFrances @alessia_alunno

[SRUK | Scleroderma & Raynaud's UK @WeAreSRUK]

Our Head of Research, Ula is at @eular_org in Barcelona, kicking off with powerful insights on ILD, digital ischemia, GI involvement & more in systemic sclerosis. A vital reminder of how far we’ve come and what’s still to come.

#EULAR2025 #SystemicSclerosis #Scleroderma

[SclerodermaSalfordManchester @SclerodermaM]

Great to lead hybrid digital ulcer consensus meeting yesterday @OfficialUoM. Expert panel (including remote colleagues in Italy and Australia) discussing and assessing photographs to provide training data for machine learning/AI.
@NCAresearchNHS

[SclerodermaSalfordManchester @SclerodermaM]

@delgaldoFrances @NCAresearchNHS

[SclerodermaSalfordManchester @SclerodermaM]

SURVEY! Seeking clinicians perspectives on oral drug treatment for SSc Raynaud's. Important Discrete Choice Experiment on how clinicians choose treatment (Dr Michael Hughes and @sclerodermaUM).

https://t.co/zFvQWJD9Bx

@WeAreSRUK
@Worldsclerofnd
@EUSTAR_org
@alessia_alunno

[SclerodermaSalfordManchester @SclerodermaM]

SURVEY! Seeking clinicians perspectives on oral drug treatment for SSc Raynaud's. Important Discrete Choice Experiment on how clinicians choose treatment (Dr Michael Hughes and @sclerodermaUM).

https://t.co/zFvQWJD9Bx

@WeAreSRUK
@Worldsclerofnd
@EUSTAR_org
@alessia_alunno

[SclerodermaSalfordManchester @SclerodermaM]

Just published in Microvascular Research: "Imaging the microvasculature using nailfold capillaroscopy in patients with Corona virus disease-2019; a cross-sectional study".
Free access to our paper until April 17th 2025:
https://t.co/pRHtljfYXu
@NCAresearchNHS

[SclerodermaSalfordManchester @SclerodermaM]

JOB ALERT! Our group is recruiting for a part-time (0.5FTE) research assistant to work on an exciting international study of digital ulcers in systemic sclerosis.
https://t.co/sTjJmES6Ri @WeAreSRUK @VersusArthritis @Worldsclerofnd @EUSTAR_org @NCAresearchNHS

[SclerodermaSalfordManchester @SclerodermaM]

NEW SURVEY for patients with systemic sclerosis (scleroderma) on the role of environmental and occupational factors in SSc.

https://t.co/4lN2gmvVJ1

@WeAreSRUK @Worldsclerofnd @VersusArthritis @alessia_alunno @delgaldoFrances @eular_org @FarrSue01 @NCAresearchNHS @RheumatologyUK

[NCA Research NHS @NCAresearchNHS]

National survey explores rheumatologists’ awareness, approaches to diagnosis & management, & training needs within systemic sclerosis
Dr Michael Hughes from @salfordco_nhs is the senior author on this @wearesruk survey https://t.co/KC1DKia7gw
@SclerodermaM

[NCA Research NHS @NCAresearchNHS]

This study particularly needs females aged 52-59 currently - the research appointment @salfordco_nhs only takes an hour and could help to improve care for people with systemic sclerosis (we're looking for people without the condition)

[BSR @RheumatologyUK]

🚨 We are delighted to share the newly updated Systemic Sclerosis guideline, published today!

Key updates include interstitial lung disease, pulmonary hypertension, and more.

Read more: https://t.co/3GtPcPJu5A

@WeAreSRUK